Roivant Sciences Ltd. (ROIV)

CIK 0001635088 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-08-06) · 99.1
Latest FY-2025 8-K (2026-05-20) · 99.1  |  8-K (2026-04-02) · 99.1
Q3-2025 8-K (2026-02-06) · 99.1
Q2-2025 8-K (2025-11-10) · 99.1
Q1-2025 8-K (2025-08-11) · 99.1
FY-2024 8-K (2025-05-29) · 99.1
Q3-2024 8-K (2025-02-10) · 99.1
Q2-2024 8-K (2024-11-12) · 99.1
Q1-2024 8-K (2024-08-08) · 99.1
FY-2023 8-K (2024-05-30) · 99.1  |  8-K (2023-06-28) · 99.1
Q3-2023 8-K (2024-02-13) · 99.1
Q2-2023 8-K (2023-11-13) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Document and Entity Information
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statements of Operations (P)
Condensed Consolidated Statements of Comprehensive Loss
—
Consolidated Statements of Comprehensive Income (loss)
Consolidated Statements of Comprehensive (loss) Income
Consolidated Statements of Shareholders Equity
Consolidated Statements of Shareholders' Equity and Redeemable Noncontrolling Interest
Consolidated Statements of Cash Flows
Notes
Cash, Cash Equivalents and Marketable Securities
Cash, Cash Equivalents, and Marketable Securities
—
Certain Balance Sheet Components
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Description of Business and Liquidity
Discontinued Operations
Earn-out Shares
—
Earn-out Shares, Public Warrants and Private Placement Warrants
Equity Method Investments
Fair Value Measurements
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Intangible Assets
Leases
—
Long-term Debt
Net (loss) Income Per Common Share
Net Income (loss) Per Common Share
Net Income Per Common Share
—
Net Loss Per Common Share
—
Pay Vs Performance Disclosure
—
Recent Transactions
Recent Transactions and Developments
Revenue
Segment Information
Share-based Compensation
Share-based Compensation and Other Compensation Plans
Shareholders' Equity
Subsequent Events
Summary of Significant Accounting Policies